These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
816 related articles for article (PubMed ID: 6845551)
21. [Patients treated for gynecologic cancer after use of oral contraceptives and IUD]. Szegvári M; Altmayer P Orv Hetil; 1979 Apr; 120(13):756-8. PubMed ID: 424201 [No Abstract] [Full Text] [Related]
22. Clinical evaluation of side effects of current oral contraceptives. Nelson JH J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975 [No Abstract] [Full Text] [Related]
23. [Who is still afraid of the pill today? The development of hormonal contraception ('the pill') in the last 20 years. Current status]. van Vliet M Tijdschr Ziekenverpl; 1982 Oct; 35(20):659-63. PubMed ID: 6923669 [No Abstract] [Full Text] [Related]
24. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Shulman LP Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825 [TBL] [Abstract][Full Text] [Related]
25. The pill, breast and cervical cancer, and the role of progestogens in arterial disease. Lincoln R Fam Plann Perspect; 1984; 16(2):55-63. PubMed ID: 6373360 [No Abstract] [Full Text] [Related]
29. Oral contraceptives: clinical problems and choices. Jones DE; Halbert DR Am Fam Physician; 1975 Oct; 12(4):115-23. PubMed ID: 1163414 [No Abstract] [Full Text] [Related]
30. [Our experience with continuin]. Sándor C; Ferenc H; Géza V Orv Hetil; 1977 Jan; 118(2):87-9. PubMed ID: 831202 [No Abstract] [Full Text] [Related]
31. [Hormonal contraception in young girls]. Hamvas F; Csömör S; Tóth K; Kovács I Orv Hetil; 1977 Dec; 118(51):3097-8. PubMed ID: 593697 [No Abstract] [Full Text] [Related]
33. Hepatic tumors and oral contraceptives. Mallory A Gastroenterology; 1978 Sep; 75(3):517-8. PubMed ID: 680514 [No Abstract] [Full Text] [Related]
34. [Colpocytological patterns after prolonged treatment with combined estroprogestinic drugs]. Vernotico V; Zanella B Minerva Ginecol; 1975 Jun; 27(6):448-56. PubMed ID: 1153121 [No Abstract] [Full Text] [Related]
35. [Biochemical and steroidal indicators in the use of Monogest, a progesterone contraceptive]. Kobilková J; Zizkovská E; Trnka V Cesk Gynekol; 1981 Aug; 46(7):540-1. PubMed ID: 7285177 [No Abstract] [Full Text] [Related]
36. [Complications of therapy in gynecology (morphological studies of the effects of female sex hormones and like substances) (review) (author's transl)]. Dallenbach-Hellweg G Verh Dtsch Ges Pathol; 1972; 56():252-83. PubMed ID: 4130829 [No Abstract] [Full Text] [Related]
37. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women. Drill VA J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399 [TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives and cardiovascular disease (second of two parts). Stadel BV N Engl J Med; 1981 Sep; 305(12):672-7. PubMed ID: 7022211 [No Abstract] [Full Text] [Related]